Loading data
MRKRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 11.8 m USD | 13.47 m USD | 10.42 m USD | 11.97 m USD | 27.79 m USD |
| Operating profit | -12.89 m USD | -11.12 m USD | -14.58 m USD | -19.79 m USD | -39.48 m USD |
| Profit before tax | -12.18 m USD | -10.68 m USD | -14.04 m USD | -19.78 m USD | — |
| Income tax expense | -15.16 k USD | 49.95 k USD | 4 k USD | — | — |
| Net income (reported basis) | -12.16 m USD | -10.73 m USD | -8.24 m USD | -29.93 m USD | -41.88 m USD |
| Basic earnings per share | -0.79 USD/share | -1.19 USD/share | -0.94 USD/share | -3.58 USD/share | -5.47 USD/share |
| Diluted earnings per share | -0.79 USD/share | -1.19 USD/share | -0.94 USD/share | -3.58 USD/share | -5.47 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.